Breast Cancer Clinical Trials in Shanghai, Shanghai Municipality
107 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 107 trials
Recruiting
Phase 2
Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Metastatic Breast Cancer ( HER2 Negative)
Fudan University45 enrolled2 locationsNCT07471776
Recruiting
Not Applicable
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
Breast CancerCirculating Tumor Cell
RenJi Hospital484 enrolled1 locationNCT05360290
Recruiting
Phase 1
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.20 enrolled2 locationsNCT06503783
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 2
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
Breast Cancer
RemeGen Co., Ltd.40 enrolled1 locationNCT06178159
Recruiting
Phase 3
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Locally Advanced Breast Cancer
RenJi Hospital316 enrolled1 locationNCT04254263
Recruiting
Phase 1
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Breast CancerOvarian CancerProstate Cancer+4 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd30 enrolled2 locationsNCT06666270
Recruiting
Phase 1Phase 2
A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
Advanced Unresectable or Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.528 enrolled1 locationNCT06555068
Recruiting
Phase 3
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Triple Negative Breast Cancer(TNBC)
Biotheus Inc.360 enrolled70 locationsNCT06419621
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
Breast CancerProton TherapyIntensity Modulated Radiation Therapy+2 more
Ruijin Hospital500 enrolled1 locationNCT06826885
Recruiting
Phase 2
Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab
HER2-negative Breast CancerBRCA-Mutated Breast Carcinoma
Fudan University130 enrolled1 locationNCT06516289
Recruiting
Not Applicable
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Breast CancerLung CancersLiver Cancer+4 more
Guo ShiWei1,000,000 enrolled1 locationNCT06632886
Recruiting
Phase 2
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
Breast Cancer
Fudan University35 enrolled1 locationNCT04303988
Recruiting
clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Breast CancerBone Metastases
Fudan University500 enrolled1 locationNCT06392217
Recruiting
Phase 2
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Breast CancerAdvanced Breast Cancer
Fudan University265 enrolled1 locationNCT05949541
Recruiting
Not Applicable
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
Breast Cancer
Ruijin Hospital214 enrolled1 locationNCT04517266
Recruiting
Not Applicable
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
Breast Cancer
Ruijin Hospital1,355 enrolled1 locationNCT05976412
Recruiting
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Breast CancerSkin MicrobiomeRadiation Dermatitis+1 more
Fudan University100 enrolled1 locationNCT05032768
Recruiting
Not Applicable
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University323 enrolled8 locationsNCT04960839
Recruiting
Phase 1Phase 2
Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer
Breast CancerBone Metastases
Fudan University120 enrolled1 locationNCT04947280